Abira Medical Laboratories, LLC d/b/a Genesis Diagnostics v. Horizon Healthcare Services, Inc. d/b/a Horizon Blue Cross Blue Shield of New Jersey and Blue Cross Blue Shield of New Jersey, et al.

CourtDistrict Court, D. New Jersey
DecidedOctober 31, 2025
Docket3:24-cv-08959
StatusUnknown

This text of Abira Medical Laboratories, LLC d/b/a Genesis Diagnostics v. Horizon Healthcare Services, Inc. d/b/a Horizon Blue Cross Blue Shield of New Jersey and Blue Cross Blue Shield of New Jersey, et al. (Abira Medical Laboratories, LLC d/b/a Genesis Diagnostics v. Horizon Healthcare Services, Inc. d/b/a Horizon Blue Cross Blue Shield of New Jersey and Blue Cross Blue Shield of New Jersey, et al.) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Abira Medical Laboratories, LLC d/b/a Genesis Diagnostics v. Horizon Healthcare Services, Inc. d/b/a Horizon Blue Cross Blue Shield of New Jersey and Blue Cross Blue Shield of New Jersey, et al., (D.N.J. 2025).

Opinion

NOT FOR PUBLICATION

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY

ABIRA MEDICAL LABORATORIES, LLC d/b/a GENESIS DIAGNOSTICS,

Plaintiff, v. Civil Action No. 24-8959 (ZNQ) (JTQ)

HORIZON HEALTHCARE SERVICES, OPINION INC. d/b/a HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY AND BLUE CROSS BLUE SHIELD OF NEW JERSEY, et al.,

Defendants.

QURAISHI, District Judge THIS MATTER comes before the Court upon a Motion to Dismiss the Amended Complaint (the “Motion,” ECF No. 24) filed by Defendants Horizon Healthcare Services, Inc. d/b/a Horizon Blue Cross Blue Shield of New Jersey and Blue Cross Blue Shield of New Jersey and Defendant Horizon Healthcare of New Jersey, Inc. d/b/a Horizon NJ Health (collectively, “Defendants” or “Horizon”). Plaintiff Abira Medical Laboratories, LLC d/b/a Genesis Diagnostics (“Plaintiff”) filed a Brief in Opposition (“Opp’n Br.,” ECF No. 31), and Defendants filed a Reply (“Reply Br.,” ECF No. 32.) The Court has carefully considered the parties’ submissions and decides the Motion without oral argument pursuant to Federal Rule of Civil Procedure 78 and Local Civil Rule 78.1. For the reasons set forth below, the Court will GRANT Plaintiff’s informal request to amend the Amended Complaint and DENY Defendants’ Motion as moot. I. BACKGROUND AND PROCEDURAL HISTORY A. BACKGROUND

Plaintiff “performed clinical laboratory, pharmacy, genetics, addiction rehabilitation, and COVID-19 testing services [(“Laboratory Testing Services”)] on specimens submitted by medical service providers.” (Am. Compl. ¶ 9.) Defendants are health insurance companies registered in New Jersey. (Id. ¶¶ 7–8.) Various Laboratory Testing Services claims were “submitted on behalf of Defendant[’s] insureds.” (Id. ¶ 10.) Plaintiff asserts that the applicable contracts contained a provision obligating Defendants to pay for the Laboratory Testing Services that were provided by Plaintiff to Defendants’ insureds, members, and/or subscribers. (Id.) The assignment provision states: I hereby assign all rights and benefits under my health plan and direct payments be made to Genesis . . . for laboratory services furnished to me by Genesis . . .. I irrevocably designate authorize and appoint Genesis . . . or its assigned affiliates as my true and lawful attorney-infact for the purpose of submitting my claims and pursuing any request, disclosure, appeal, litigation or other remedies in accordance with the benefits and rights under my health plan and in accordance with any federal or state laws. If my health plan fails to abide by my authorization and makes payment directly to me, I agree to endorse the insurance check and forward it to Genesis . . . immediately upon receipt. I hereby authorize Genesis . . . or its assigned affiliates to contact me for billing or payment purposes by phone, text message, or email with the contact information that I have provided to Genesis . . ., in compliance with federal and state laws.

(Id. ¶ 11.) Plaintiff asserts Defendants “engaged in a long campaign designed to deprive Plaintiff of millions of dollars” in connection with the services Plaintiff rendered to Defendants’ subscribers and/or members. (Id. ¶ 14.) Plaintiff seeks $3,616,493.00 for 5,069 claims it purportedly submitted for Laboratory Testing Services rendered to patients enrolled in health benefit plans issued or administered by Defendants. (Id. ¶¶ 12–13.) B. PROCEDURAL HISTORY

Plaintiff filed an action against Defendants in the Superior Court of New Jersey, Law Division (the “State Court Action”). (Am. Compl. ¶ 17; Abira Medical Laboratories, LLC d/b/a Genesis Diagnostics v. Horizon Blue Cross Blue Shield of New Jersey, Inc., et al., Docket No. MER-L-2297-23.) In the state court Action, Defendants filed a motion to dismiss in lieu of filing an answer. (Am. Compl. ¶ 18.) Plaintiff asserts that “[d]uring oral argument and briefing, Defendants advised the court that all of the claims at issue involve subscribers/members/insured[s] who are members of an Employee Retirement Income Security Act (“ERISA”) health plan.” 1 (Id. ¶ 19.) Thereafter, and based on the fact that Defendants had indicated that all claims at issue involved ERISA health plans, Plaintiff filed the Complaint in this Court pursuant to 29 U.S.C.S.

§ 1132(e). (Id. ¶ 20, ECF No. 1.) Included with the Complaint was Exhibit 1, which is a spreadsheet setting forth each transaction at issue in this case. (ECF No. 3.) Thereafter, Plaintiff filed the Amended Complaint, asserting two claims against Defendants: (1) claim for benefits under ERISA; and (2) estoppel. (ECF No. 5 2.) On March 14, 2025, Defendants filed the Motion to Dismiss. (ECF No. 24.)

1 It appears that the state court granted Plaintiff leave to amend its complaint “to distinguish between its ERISA and non-ERISA claims.” (Moving Br. at 3–4.) Plaintiff thereafter filed this lawsuit. (Id.) 2 The Amended Complaint at ECF No. 5 appears to be a duplicate of ECF No. 6. (See Clerk’s Quality Control Message entered Oct. 2, 2024.) II. SUBJECT MATTER JURISDICTION Plaintiff asserts that this Court has jurisdiction over its claims pursuant to 29 U.S.C.S. § 1132(e). (Am. Compl. ¶ 33.) III. LEGAL STANDARD

A. RULE 12(B)(1) “When a motion under Rule 12 is based on more than one ground, the court should consider the 12(b)(1) challenge first because if it must dismiss the complaint for lack of subject matter jurisdiction, all other defenses and objections become moot.” Dickerson v. Bank of Am., N.A., Civ. No. 12-3922, 2013 WL 1163483, at *1 (D.N.J. Mar. 19, 2013) (citation omitted). When considering a dismissal for lack of subject matter jurisdiction, a district court’s focus is not on whether the factual allegations entitle a plaintiff to relief but rather on whether the court has jurisdiction to hear the claim and grant relief. Maertin v. Armstrong World Indus., Inc., 241 F. Supp. 2d 434, 445 (D.N.J. 2002) (citation omitted). Standing under Article III of the United States Constitution is an element of subject matter

jurisdiction. See Hartig Drug Co. Inc. v. Senju Pharm. Co., 836 F.3d 261, 269 (3d Cir. 2016). Under Rule 12(b)(1), “a court must grant a motion to dismiss if it lacks subject-matter jurisdiction to hear a claim.” In re Schering Plough Corp. Intron/Temodar Consumer Class Action, 678 F.3d 235, 243 (3d Cir. 2012). “A motion to dismiss for want of standing is . . . properly brought pursuant to Rule 12(b)(1), because standing is a jurisdictional matter.” Ballentine v. United States, 486 F.3d 806, 810 (3d Cir. 2007). When considering a Rule 12(b)(1) standing challenge, the Court must determine whether the attack is facial or factual. Schering Plough, 678 F.3d at 243. “A facial attack, as the adjective indicates, is an argument that considers a claim on its face and asserts that it is insufficient to invoke the subject matter jurisdiction of the court because . . . it does not present a question of federal law, or because . . . some other jurisdictional defect is present.” Constitution Party of Pa. v. Aichele, 757 F.3d 347, 358 (3d Cir. 2014). When reviewing a facial attack, a “court must only consider the allegations of the complaint and documents referenced therein and attached thereto,

in the light most favorable to the plaintiff.” Gould Elec. Inc. v.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Conley v. Gibson
355 U.S. 41 (Supreme Court, 1957)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Karen Malleus v. John George
641 F.3d 560 (Third Circuit, 2011)
Burtch v. Milberg Factors, Inc.
662 F.3d 212 (Third Circuit, 2011)
Krim M. Ballentine v. United States
486 F.3d 806 (Third Circuit, 2007)
Fowler v. UPMC SHADYSIDE
578 F.3d 203 (Third Circuit, 2009)
Maertin v. Armstrong World Industries, Inc.
241 F. Supp. 2d 434 (D. New Jersey, 2002)
Constitution Party of Pennsylv v. Carol Aichele
757 F.3d 347 (Third Circuit, 2014)
Hartig Drug Co Inc v. Senju Pharmaceutical Co Ltd
836 F.3d 261 (Third Circuit, 2016)
Mortensen v. First Federal Savings & Loan Ass'n
549 F.2d 884 (Third Circuit, 1977)

Cite This Page — Counsel Stack

Bluebook (online)
Abira Medical Laboratories, LLC d/b/a Genesis Diagnostics v. Horizon Healthcare Services, Inc. d/b/a Horizon Blue Cross Blue Shield of New Jersey and Blue Cross Blue Shield of New Jersey, et al., Counsel Stack Legal Research, https://law.counselstack.com/opinion/abira-medical-laboratories-llc-dba-genesis-diagnostics-v-horizon-njd-2025.